KOREA PHARMA

The current price of 032300 is 18970 KRW — it has increased by 0.90% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KOREA PHARMA stocks are traded under the ticker 032300.

032300 stock is 4.80% volatile and has beta coefficient of 0.91. Check out the list of the most volatile stocks — is KOREA PHARMA there?

Yes, you can track KOREA PHARMA financials in yearly and quarterly reports right on TradingView.

032300 stock has fallen by 6.32% compared to the previous week, the month change is a 11.56% fall, over the last year KOREA PHARMA has showed a 16.62% decrease.

032300 net income for the last quarter is ‪−735.59 M‬ KRW, while the quarter before that showed ‪1.25 B‬ KRW of net income which accounts for −158.93% change. Track more KOREA PHARMA financial stats to get the full picture.

Yes, 032300 dividends are paid annually. The last dividend per share was 50.00 KRW. As of today, Dividend Yield (TTM)% is 0.27%. Tracking KOREA PHARMA dividends might help you take more informed decisions.

Like other stocks, 032300 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOREA PHARMA stock right from TradingView charts — choose your broker and connect to your account.

032300 reached its all-time high on Jan 21, 2021 with the price of 94800 KRW, and its all-time low was 13100 KRW and was reached on Aug 24, 2020.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 289.00 employees. See our rating of the largest employees — is KOREA PHARMA on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOREA PHARMA technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOREA PHARMA stock shows the strong sell signal. See more of KOREA PHARMA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOREA PHARMA EBITDA is ‪8.65 B‬ KRW, and current EBITDA margin is 10.40%. See more stats in KOREA PHARMA financial statements.